Omega-3E treatment regulates matrix metalloproteinases and prevents vascular reactivity alterations in diabetic rat aorta

Canadian Journal of Physiology and Pharmacology

Volumn 87, Issue 12, 2009, Pages 1063-1073

  Zeydanli, Esma N ^a   Turan, Belma ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

AR relaxation responses; Antioxidant; Oxidative stress; Type 1 diabetes; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; CYCLIC AMP; ENDOTHELIN 1; GELATINASE A; GELATINASE B; ISOPRENALINE; NITRITE; OMEGA 3 FATTY ACID; PROTEIN KINASE C; TISSUE INHIBITOR OF METALLOPROTEINASE 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; AORTA; CELL STRUCTURE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; HEART PROTECTION; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; STREPTOZOCIN DIABETES; THORACIC AORTA; VASCULAR DISEASE;

ANIMALS; AORTA, THORACIC; BLOTTING, WESTERN; CYCLIC AMP; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC ANGIOPATHIES; FATTY ACIDS, OMEGA-3; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MUSCLE, SMOOTH, VASCULAR; NITRITES; RATS; RATS, WISTAR; VITAMIN E;

EID: 76549133258     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y09-112     Document Type: Conference Paper

References (45)

1. American Diabetes Association. 2002. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. Diabetes Care, 25(1): S50-S60. doi:10.2337/diacare.25. 2007.S50.
2. Battell, M.L., Delgatty, H.L., and McNeill, J.H. 1998. Sodium selenate corrects glucose tolerance and heart function in STZ diabetic rats. Mol. Cell. Biochem. 179(1-2): 27-34. doi:10.1023/A:1006819227506. PMID:9543346.
3. Bendeck, M.P., Conte, M., Zhang, M., Nili, N., Strauss, B.H., and Farwell, S.M. 2002. Doxycycline modulates smooth muscle cell growth, migration, and matrix remodeling after arterial injury. Am. J. Pathol. 160(3): 1089-1095. PMID:11891205.
4. Boulanger, C., and Lüscher, T.F. 1990. Release of endothelin from the porcine aorta: inhibition by endothelium-derived nitric oxide, J. Clin. Invest. 85(2): 587-590. doi:10.1172/JC1114477. PMID:2153712.
5. Chew, P., Yuen, D.Y., Koh, P., Stefanovic, N., Febbraio, M.A., Kola, I., et al. 2009. Site-specific antiatherogenic effact of the antioxidant ebselen in the diabetic apolipoprotein E-deficient mouse. Arterioscler. Thromb. Vasc. Biol. 29(6): 823-830. doi:10.1161/atvbaha.109.186619. PMID:19325139.
6. Cbisolm, G.M., and Steinberg, D. 2000. The oxidative modification hypothesis of atherogenesis: an overview. Free Radic. Biol. Med. 28(12): 1815-1826. doi:10.1016/50891-5849(00)00344-0. PMID:10946223.
7. Clements, R.T., Sodha, N.R., Feng, J., Boodhwani, M., Liu, Y., Mieno, S., et al. 2009. Impaired coronary microvascular dilation correlates with enhanced vaseular smooth muscle MLC phosphorylation in diabetes. Microcirculation, 16(2): 193-206. doi:10.1080/10739680802461950. PMID:19152178.
8. Colwell, J.A., Winocour, P.D., Lopes-Virella, M., and Halushka, P.V. 1983. New concepts about the pathogenesis of atheroxlerosis in diabetes mellitus. Am. J. Med. 75(5 B): 67-80. doi:10.1016/0002-9343(83)90256-5. PMID:6424441.
9. Ergul, A., Portik-Dobos, V., Giulumian, A.D., Molero, M.M., and Fuchs, L.C. 2003. Stress upregulates arterial matrix metalloproteinase expression and activity via endothelin A receptor activation. Am. J. Physiol. Heart Circ. Physiol. 285(5): H2225-H2232. PMID: 12842810.
10. Erkkil̈, A.T., Lichtenstein, A.H., Mozaffarian, D., and Herrington, D.M. 2004. Fish intake is associated with a reduced progression of coronary artery atherosclerosis in postmenopausal women with coronary artery disease. Am. J. Clin. Nutr. 80(3): 626-632. PMID:15321802.
11. Fernandez-Patron, C., Stewart, K.G., Zhang, Y., Koivunen, E., Radomski, M.W., and Davidge, S.T., 2000. Vaxular matrix metalloproteinase-2-dependent cleavage of calcitonin gene-related peptide promotes vasoconstriction. Circ. Res. 87(8): 670-676. PMID:11029402.
12. Gao, C.Q., Sawicki, G., Suarez-Pinzon, W.L., Csont, T., Wozniak, M., Ferdinandy, P., and Schulz, R. 2003. Matrix metalloproteinase-2 mediates cytokine-induced myocardial contractile dysfunction. Cardiovasc. Res. 57(2): 426-433. doi:10.1016/S0008-6363(02)00719-8. PMID:12566115.
13. Geelen, A., Brouwer, I.A., Zock, P.L., and Katan, M.B. 2004. Antiarrhythtmic effects of n-3 fatty acids: evidence from human studies. Curr. Opin. Lipidol. 15(1): 25-30. doi:10.1097/00041433-200402000-00006. PMID:15166805.
14. Gumieniczek, A., Hopkała, H., Wójtowicz, Z., and Nikołajuk, J. 2002. Changes in antioxidant status of heart muscle tissue in experimental diabetes in rabbits. Acta Biochim. Pol. 49(2): 529-535. PMID:12362995.
15. Gurdal, H., Can, A., and Ugur, M. 2005. The role of nitric oxide synthase in reduced vasocontractile responsiveness induced by prolonged alpha1-adrenergic receptor stimulation in rat thoracic aorta. Br. J. Pharmacol. 145(2): 203-210. doi:10.1038/sj.bjp.0706177. PMID:15753950.
16. Hardman, J.G. 1984. Cyclic nucleotides and regulation of vascular smooth muscle. J. Cardiovasc. Pharmacol. 6(4 Suppl 4): S639-S645. doi:10.1097/00005344-198406004-00010. PMID:6083406.
17. Ignarro, L.J., Cirino, G., Casini, A., and Napoli, C. 1999. Nitric oxide as a signaling molecule in the vascular system: an overview. J. Cardiovasc. Pharmacol. 34(6): 879-886. doi:10.1097/00005344-199912000-00016. PMID:10598133.
18. Inoguchi, T., Li, P., Umeda, F., Yu, H.Y., Kakimoto, M., Imamura, M., et al. 2000. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes, 49(11): 1939-1945. doi:10.2337/diabetes.49.11.1939. PMID:11078463.
19. Jensen, T., Stender, S., Goldstein, K., Hølmer, G., and Deckert, T. 1989. Partial normalization by dietary cod-liver oil of increased microvascular albumin leakage in patients with insulin-dependent diabetes and albuminuria. N. Engl. J. Med. 321(23): 1572-1577. PMID:2685599.
20. Kamata, K., Miyata, N., Abiru, T., and Kasuya, Y. 1992. Functional changes in vascular smooth muscle and endothelium of arteries during diabetes mellitus. Life Sci. 50(19): 1379-1387. doi:10.1016/0024-3205(92)90256-O. PMID:1374144.
21. Kesavulu, M.M., Kameswararao, B., Apparao, Ch., Kumar, E.G., and Harinarayan, C.V. 2002. Effect of omega-3 fatty acids on lipid peroxidation and antioxidant enzyme status in type 2 diabetic patients. Diabetes Metab. 28(1): 20-26. PMID:11938024.
22. Kiersztan, A., Baranska, A., Hapka, M., Lebiedzinska, M., Winiarska, K., Dudziak, M., and Bryla, J. 2009. Differential action of methylselenocysteine in control and alloxan-diabetic rabbits. Chem. Biol. Interact. 177(2): 161-171. doi:10.1016/j.cbi.2008.10.022. PMID:19010315.
23. Kuzuya, M., Asai, T., Kanda, S., Maeda, K., Cheng, X.W., and Iguchi, A. 2001. Glycation cross-links inhibit matrix metalloproteinase-2 activation in vascular smooth muscle cells cultured on collagen lattice. Diabetologia, 44(4): 433-436. doi:10.1007/s001250051640. PMID:11357473.
24. Leaf, A., Kang, J.X., Xiao, Y.F., and Billman, G.E. 2003. Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation, 107(21): 2646-2652. doi:10.1161/01.CIR.0000069566.78305.33. PMID:12782616.
25. Lee, J.H., and Ragolia, L. 2006. AKT phosphorylation is essential for insulin-induced relaxation of rat vascular smooth muscle cells. Am. J. Physiol. Cell Physiol. 291(6): C1355-C1365. doi:10.1152/ajpeell.00125.2006. PMID:16855220.
26. Lee, T.S., Saltsman, K.A., Ohashi, H., and King, G.L. 1989. Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications. Proc. Nail. Mad. Sci. U.S.A. 86(13): 5141-5145. doi:10.1&73/pnas.86.13.5141. PMID:2740348.
27. Malasanos, T.H., and Stacpoole, P.W. 1991. Biological efftcts of omega-3 fatty acids in diabetes mellitus. Diabetes Care, 14(12): 1160-1179. doi:10.2337/diacare.14.12.1160. PMID:1773702.
28. Matsumoto, T., Kobayashi, T., and Kamata, K. 2008. Relationships among ET-1, PPARgamma, oxidative stress and endothelial dysfunction in diabetic animals. J. Smooth Muscle Res. 44(2): 41-55. doi:10.1540/jsmr.44.41. PMID:18552452.
29. Moshal, K.S., Tyagi, N., Moss, V., Henderson, B., Steed, M., Ovechkin, A., et al. 2005. Early induction of matrix metalloproteinase-9 transuces signaling in human heart end stage failure. J. Cell. Mol. Med. 9(3): 704-713. doi:10.1111/j.1582-4934. 2005.tb00501.x. PMID:16202218.
30. Nettleton, J.A., and Katz, R. 2005. n-3 Long-chain polyunsaturated fatty acids in type 2 diabetes: a review. J. Am. Diet. Assoc. 105(3): 428-440. doi:10.1016/j.jada.2004.11.029. PMID:15746832.
31. Pierce, G.N., and Dhalla, N.S. 1985. Mechanisms of the defact in cardiac myofibrillar function during diabetes. Am. J. Physiol. Endocrinol. Metab. 248: E170-E175.
32. Portik-Dobos, V., Anstadt, M.P., Hutchinson, J., Bannan, M., and Ergul, A. 2002. Evidence for a matrix metalloproteinase induction/activation system in arterial vasculature and decreased synthesis and activity in diabetes. Diabetes, 51(10): 3063-3068. doi:10.2337/diabetes.51.10.3063. PMID:12351448.
33. Sayar, K., Ugur, M., Gurdal, H., Onaran, O., Hotomaroglu, O., and Turan, B. 2000. Dietary selenium and vitamin E intakes alter beta-adrenergic response of L-type Ca-current and beta-adrenoceptor-adenylate cyclase coupling in rat heart. J. Nutr. 130(4): 733-740. PMID:10736322,
34. Siwik, D.A., Pagano, P.J., and Colucci, W.S. 2001. Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts. Am. J. Physiol. Cell Physiol. 280(1): C53-C60. PMID:11121376.
35. Skalska, A.B., Pietrzycka, A., and Stepniewski, M. 2009. Correlation of endothelin 1 plasma levels with plasma antioxidant capacity in elderly patients treated for hypertension. Clin. Biochem. 42(4-5): 358-364. doi:10.1016/j.clinbiochem.2008.11.002. PMID:19046960.
36. Son, S.M. 2007. Role of vascular reactive oxygen species in development of vascular abnormalities in diabetes. Diabetes Res. Clin. Pract. 77(Suppl 1): S65-S70. doi:10.1016/j.diabres.2007.01.036. PMID:17467110.
37. Sullivan, S., and Sparks, H.V. 1979. Diminished contractile response of aortas from diabetic rabbits. Am. J. Physiol. 236(2): H301-H306. PMID:420312.
38. Tavazzi, L., Tognoni, G., Franzosi, M.G., Lath, R., Maggioni, A.P., Marchioli, R., et al.; GISSI-HF Investigators. 2004. Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure. Eur. J. Heart Fail. 6(5): 635-641. PMID:15302013.
39. Tuncay, E., Seymen, A.A., Tanriverdi, E., Yaras, N., Tandogan, B., Ulusu, N.N., and Turan, B. 2007. Gender related differential effects of omega-3E treatment on diabetes-induced left ventricular dysfunction. Mol. Cell. Biochem. 304(1-2): 255-263. doi:10.1007/s11010-007-9508-4. PMID:17530185.
40. Tunctan, B., Okur, H., Calisir, C.H., Abacioglu, H., Cakici, I., Kanzik, I., and Abacioglu, N. 1998. Comparison of nitric oxide production by monocyte/macrophages in healthy subjects and patients with active pulmonary tuberculosis, Pharmacol. Res. 37(3): 219-226. doi:10.1006/phrs.1997.0284. PMID:9602471.
41. Thran, B., Désilets, M., Acan, L.N., Hotomaroglu, O., Vannier, C., and Vassort, G. 1996. Oxidative effects of selenite on rat ventricular contractility and Ca movements. Cardiovasc, Res. 32(2): 351-361. doi:10.1016/0008-6363(96)00071-5. PMID:8796123.
42. Uemura, S., Matsushita, H., Li, W., Glassford, A.J., Asagami, T., Lee, K.H., et al. 2001. Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress. Circ. Res. 88(12): 1291-1298. doi:10.1161/hh1201.092042. PMID:11420306.
43. Ulusu, N.N., and Turan, B. 2005. Beneficial effects of selenium on some enzymes of diabetic rat heart. Biol. Trace Elem. Res. 103(3): 207-216. doi:10.1385/bter:103:3:207. PMID:15784954.
44. von Schacky, C., Angerer, P., Kothny, W., Theisen, K., and Mudra, H. 1999. The effect of dietary omega-3 fatty acids on coronary atherosclerosis: a randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 130(7): 554-562. PMID:10189324.
45. Wolff, S.P., and Dean, R.T. 1987. Glucose autoxidation and protein modification: the potential role of 'autoxidative glycosylation' in diabetes. Biochem. J. 245(1): 243-250. PMID:3117042.